Communiqués ANI Pharmaceuticals, Inc.

Actions

ANIP

US00182C1036

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 28/09/2026			Varia. 5j.	Varia. 1 janv.
74,83 ^USD	+1,12%		-1,72%	-5,21%

23/09	ANI Pharmaceuticals, Inc. : Oppenheimer passe à neutre sur le dossier	ZM
23/09	ANI Pharmaceuticals obtient l’approbation de la FDA pour des comprimés génériques d’évérolimus	MT

Communiqués

23/09	ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension	AQ
03/09	ANI Pharmaceuticals to Present at September Investor Conferences	AQ
28/08	ANI Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3)	PU
24/08	ANI Pharmaceuticals : Appoints Henry Gosebruch to Board of Directors	PU
24/08	ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors	AQ
07/08	ANI: Q2 Earnings Snapshot	AQ
07/08	ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results	AQ
27/07	ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET	AQ
24/07	ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET	AQ
16/07	ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter	AQ
13/07	ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis	AQ
27/05	ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference	AQ
13/05	ANI Pharmaceuticals : Corporate Presentation May 2026	PU
08/05	ANI: Q1 Earnings Snapshot	AQ
08/05	ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance	AQ
27/04	ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET	AQ
24/04	ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET	AQ
20/04	ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity	AQ
13/04	ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules	AQ
08/04	ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet	AQ
07/04	ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology	AQ
03/03	ANI Pharmaceuticals : Corporate Presentation March 2026	PU
02/03	ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance	AQ
27/02	ANI: Q4 Earnings Snapshot	AQ
27/02	ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance	AQ